These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2349428)

  • 1. [Measurement of the effect of a bronchodilator agent].
    Fitting JW
    Schweiz Rundsch Med Prax; 1990 May; 79(22):688-90. PubMed ID: 2349428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of reversibility in airway obstruction].
    Toczyska I; Lubiński W; Chciałowski A
    Pneumonol Alergol Pol; 2004; 72(11-12):499-504. PubMed ID: 16329350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilating drugs and airway reactivity.
    Guerrin F; Robin H; Lahoutte C; Voisin C
    Eur J Respir Dis Suppl; 1980; 106():71-5. PubMed ID: 6110561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre.
    Weir DC; Sherwood Burge P
    Thorax; 1991 Jan; 46(1):43-5. PubMed ID: 1831301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standards in evaluating the test of obstruction reversibility based on the flow-volume curves].
    Lis G; Hałuszka J
    Pneumonol Alergol Pol; 1991; 59(11-12):20-4. PubMed ID: 1843895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchodilator test: is 9% of the predicted value the same as 12% of the initial value].
    López Neyra A; Villa Asensi JR; Gimeno Díaz de Atauri A; González Alvarez MI; Romero Andujar F; Almería Gil E
    An Pediatr (Barc); 2009 May; 70(5):413-7. PubMed ID: 19375993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The analysis of bronchial obstruction and its reversibility after bronchodilators using a study of "density-effect" on maximum flow].
    Teculescu D; Racineux JL
    Rev Mal Respir; 1991; 8(1):29-37. PubMed ID: 2034854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of volume-adjusted maximal mid-expiratory flow (Iso-volume FEF25-75%) in assessing airway responsiveness to inhaled bronchodilator in asthmatics.
    Boggs PB; Bhat KD; Vekovius WA; Debo MS
    Ann Allergy; 1982 Mar; 48(3):139-42. PubMed ID: 7065476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bronchodilator response in elderly patients].
    Quadrelli SA; Roncoroni AJ; Sacerdotti A
    Medicina (B Aires); 2001; 61(3):257-61. PubMed ID: 11474869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tiotropium on the pulmonary diffusing capacity.
    Gonlugur U
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation.
    De Backer JW; Vos WG; Devolder A; Verhulst SL; Germonpré P; Wuyts FL; Parizel PM; De Backer W
    J Biomech; 2008; 41(1):106-13. PubMed ID: 17698073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of bronchodilator response through changes in lung volumes in chronic airflow obstruction.
    Figueroa-Casas JB; Diez AR; Rondelli MP; Figueroa-Casas MP; Figueroa-Casas JC
    Medicina (B Aires); 2003; 63(5):377-82. PubMed ID: 14628645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to bronchodilators.
    Shim C
    Clin Chest Med; 1989 Jun; 10(2):155-64. PubMed ID: 2567648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immediate effect of sodium cromoglycate on the airway.
    Hughes D; Mindorff C; Levison H
    Ann Allergy; 1982 Jan; 48(1):6-8. PubMed ID: 6798903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cardiorespiratory effects of rimiterol and terbutaline aerosols.
    Harris L
    Bull Physiopathol Respir (Nancy); 1974; 10(6):801-10. PubMed ID: 4156915
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing bronchodilator responsiveness in infants using partial expiratory flow-volume curves.
    Sheikh S; Castile R; Hayes J; McCoy K; Eid N
    Pediatr Pulmonol; 2003 Sep; 36(3):196-201. PubMed ID: 12910580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related protection against histamine-induced bronchoconstriction by inhaled salmeterol.
    Maconochie JG; Denyer LH; Hassani H
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):329-34. PubMed ID: 7952793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.